CCC Intelligent Solutions Holdings Inc. (CCCS) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlights positive financial performance, with strong EBITDA margins and revenue growth. The Q&A session reveals optimism regarding AI solutions, casualty business growth, and successful client wins like Liberty Mutual. Despite minor setbacks like EvolutionIQ's delayed contribution and lower gross margins, the overall sentiment remains positive due to strategic investments and operational changes. Share repurchases further enhance shareholder returns, and the guidance remains optimistic. These factors collectively indicate a likely positive stock price movement.
Key Financial Performance
Total Revenue $267 million, up 12% year-over-year. Approximately 5 points of growth driven by cross-sell, upsell, and adoption of solutions, 3 points from new logos, and 4 points from EvolutionIQ. Industry claim volumes declined 6% year-over-year, representing a 1 percentage point headwind to growth.
Adjusted EBITDA $110 million, up 8% year-over-year. Adjusted EBITDA margin was 41%. Growth attributed to revenue flow-through and phasing of costs into the fourth quarter.
Adjusted Gross Profit $199 million, with an adjusted gross profit margin of 75%, down from 78% last year. Decline due to higher depreciation from new solutions, a one-time write-off of a discontinued solution, and revenue mix.
Free Cash Flow $79 million in Q3, up from $49 million in the prior year period. Trailing 12-month free cash flow was $255 million, up 28% year-over-year. Improvement driven by strong collections and favorable working capital timing.
Stock-Based Compensation 15% of revenue in Q3, down from 24% in Q1 and 18% in Q2. Expected to trend down further in Q4 and into 2026.
Software Gross Dollar Retention (GDR) 99%, consistent with prior years, reflecting strong client retention.
Software Net Dollar Retention (NDR) 105%, down from 107% in Q2 2025, primarily due to timing of deals.
Share Repurchases 4.8 million shares repurchased in Q3 for $45 million. Year-to-date repurchases total approximately 30 million shares for $280 million.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI-based solutions: Expanded vision AI use cases to enhance core software capabilities in routing, estimating, and workflow. Launched Medhub for auto casualty, an AI-powered medical record synthesis solution.
Mobile Jumpstart: Accelerated adoption with over 1 million AI-based repair estimates generated annually, reducing estimate preparation time from 30 minutes to under 2 minutes.
Build Sheets: Adopted by over 5,500 repair facilities, enhancing part selection accuracy.
Liberty Mutual partnership: Transitioning a substantial portion of their casualty business to CCC's platform, expected to be at full run rate by mid-2026.
Casualty business growth: Outpacing overall company growth, with potential to match or exceed the scale of the auto physical damage insurance business.
Operational efficiency: AI solutions like Intelligent Reinspection and First Look are reducing cycle times and improving claim outcomes.
Free cash flow: Strong performance with $79 million in Q3, up 28% year-over-year.
EvolutionIQ integration: Integrated AI-powered injury claims resolution capabilities into CCC's auto casualty suite, unlocking cross-sell opportunities.
Organizational investments: Refined go-to-market strategy, separated Chief Product Officer and Chief Technology Officer roles, and enhanced client engagement with new talent.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Regulatory Risks: The forward-looking statements made by the company are subject to risks and uncertainties, including those discussed under the heading 'Risk Factors' in the 2024 annual report on Form 10-K filed with the SEC. This indicates potential regulatory hurdles or compliance challenges that could impact the company's plans and results.
Economic Pressures on Insurance Affordability: A recent Guardian service study highlighted that 1 in 4 Americans have downgraded or dropped insurance to free up cash, and 1 in 3 would temporarily go without coverage to afford basic necessities. This poses a challenge for CCC's insurance clients, who are focused on improving operational cost efficiency to make insurance more affordable.
Medical Inflation and Complexity: Medical inflation and increasing complexity in injury claims are growing challenges for insurers, which could impact CCC's casualty business and its ability to deliver solutions that address these issues effectively.
Adoption and Integration Risks: The adoption of CCC's AI-based solutions requires rigorous testing and piloting by clients, which could delay full implementation and impact the pace of revenue growth. Additionally, the integration of EvolutionIQ's capabilities into CCC's platform presents execution risks.
Supply Chain and Operational Challenges for Repair Facilities: Repair facilities face growing pressure to handle increasingly complex vehicles and meet higher consumer expectations. This could impact the adoption of CCC's solutions and the overall efficiency of the repair ecosystem.
Organizational and Strategic Execution Risks: The company is undergoing structural changes, including separating the roles of Chief Product Officer and Chief Technology Officer and refining its go-to-market strategy. These changes, while aimed at long-term growth, carry risks of execution and potential disruption.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Expectations: For Q4 2025, revenue is expected to be between $272 million to $277 million, representing 10% to 12% growth year-over-year. For the full year 2025, revenue is projected to be between $1.051 billion to $1.056 billion, reflecting 12% year-over-year growth at the midpoint.
Adjusted EBITDA Projections: For Q4 2025, adjusted EBITDA is expected to range from $106 million to $111 million, with a 40% adjusted EBITDA margin at the midpoint. For the full year 2025, adjusted EBITDA is projected to be between $423 million to $428 million, with a 40% adjusted EBITDA margin at the midpoint and 41% at the high end of the range.
Long-term Growth and Margin Expansion: The company expects to resume margin progression in 2026, with continued investments in AI-enabled solutions and organizational enhancements to drive long-term growth.
Casualty Business Growth: The casualty business is expected to grow faster than the overall company growth and may reach or exceed the scale of the auto physical damage insurance business over time. The transition of Liberty Mutual's casualty business to CCC's platform is expected to be at full run rate by mid-2026.
AI and Emerging Solutions: The company plans to scale AI-powered solutions, such as EvolutionIQ and Medhub, across its client base, unlocking new growth opportunities. Emerging solutions currently represent the fastest-growing portion of the portfolio, contributing over 2 points of growth in Q3 2025.
Strategic Investments: Investments in organizational changes, talent acquisition, and multisided network capabilities are expected to enhance client relationships and drive long-term value creation. These investments are not expected to impact margins going forward.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase Program: In Q3, CCC completed open market repurchases of 4.8 million shares of CCC common stock for about $45 million. The company has been active in October as well, bringing the total year-to-date repurchase to approximately 30 million shares for approximately $280 million under the previously announced $300 million share repurchase program.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you talk about the monetization perspective of AI solutions for a client that increased AI usage from 15% to 40%?
A:The company has expanded its vision AI use cases across various claims workflows, such as Estimate-STP and Intelligent Reinspection. AI adoption can increase revenue by about 50% for clients fully deploying AI solutions on top of core offerings.
Q:Can you clarify the EvolutionIQ contribution and why it was 4% instead of the expected 5%?
A:The EvolutionIQ contribution was 4% in Q3 and is expected to increase to 5% in Q4. The slight slippage was due to timing delays in client deployments, not revenue loss.
Q:What are the scenarios for achieving the higher end of the 7%-10% revenue growth target for next year?
A:Growth depends on adoption of emerging solutions like Estimate-STP and Intelligent Reinspection, casualty solutions, and new products like workers' comp solutions. Organizational changes aim to address client needs for broader solutions and process changes.
Q:What is driving growth in the casualty business, and how do market factors like inflation impact it?
A:Medical inflation and affordability issues are driving demand for casualty solutions. Investments in the casualty platform and its differentiated features are also contributing to growth.
Q:How does the core business growth look when excluding EvolutionIQ, and what is the outlook for steady-state growth?
A:Core business growth was about 8% in Q3, excluding EvolutionIQ. Emerging solutions and large customer multiproduct adoption provide confidence in steady-state growth, though $100 million in annual revenue growth is still needed.
Q:Can you provide details on new logo contributions and the types of customers being landed?
A:New logos contributed about 3 points of growth, with a mix of repair facilities, part suppliers, and carriers. This is expected to moderate to 2 points in the long term due to market leadership.
Q:Did the claims headwind decrease with lighter declines in claims, and what are the monthly trends?
A:Claims were down 6% in Q3, with a 1-point headwind on growth. The headwind is expected to persist in Q4. Claim inflation has moderated, and there are more rate decrease filings by carriers.
Q:What is the market share and competitive landscape for the casualty business?
A:Most casualty claims are processed using software, though some manual processes remain. The market is competitive, with a mix of providers offering solutions.
Q:What changes are being made to address customer needs for higher-level solutions, and how will this impact margins?
A:Investments are being made in go-to-market strategies and product development, including separating the Chief Product Officer and Chief Technology Officer roles. These changes are operationally important but not financially material, with margin expansion expected next year.
Q:Does the Liberty Mutual win create a referenceability halo effect for other top 20 carriers?
A:References played a significant role in Liberty Mutual's decision, and the win validates the company's investments in casualty solutions, potentially aiding future client wins.
Q:Is there cyclicality in medical insurance claims, and how does it compare to auto claims?
A:Medical claims are less cyclical than auto claims due to their higher dollar value, which leads to more consistent filing.
Q:What caused the lower gross margins in Q3, and what was the discontinued solution?
A:Lower gross margins were due to higher depreciation from new solutions, product mix (casualty has higher costs), and a $2 million write-off for a discontinued solution. The discontinued solution was not material and was part of regular portfolio assessment.
Q:How are transactional revenues impacted by declining claims volumes?
A:Transactional revenues are impacted by a 1-point headwind due to declining claims volumes, but overall growth offsets this impact.
Q:Is there competition in the casualty business from companies offering both APD and casualty solutions?
A:The market has a mix of providers, and while some offer single-point solutions, the company focuses on its differentiated offerings to stay competitive.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the specific market share in the casualty business and the exact details of the discontinued solution. Additionally, while they discussed the impact of declining claims volumes on transactional revenues, they did not provide precise figures for the absolute decline in transactional revenues.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI tool
APD casualty
CCC AI
CCC ecosystem
CCC platform
CCC term
EvolutionIQ
Intelligent Reinspection
ability efficiency
auto casualty
automation
base insurer
capability client
casualty client
casualty opportunity
claim CCC
claim ecosystem
claim resolution
client conversation
consumer experience
creation insurance
demand
efficiency consumer
evolution
example insurer
gain
gap
injury claim
insurance client
market value
momentum
outcome
relationship
repair estimate
repairer
request
result value
role
scale
takeaway client
talent
theme
trend confidence
value creation
workflow AI
CCCS Transcript
CCC Intelligent Solutions Holdings Inc. (CCCS) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call highlights positive financial performance, with strong EBITDA margins and revenue growth. The Q&A session reveals optimism regarding AI solutions, casualty business growth, and successful client wins like Liberty Mutual. Despite minor setbacks like EvolutionIQ's delayed contribution and lower gross margins, the overall sentiment remains positive due to strategic investments and operational changes. Share repurchases further enhance shareholder returns, and the guidance remains optimistic. These factors collectively indicate a likely positive stock price movement.
CCC Intelligent Solutions Holdings Inc. (CCCS) Presents At Goldman Sachs Communacopia + Technology Conference 2025 Transcript
Neutral9-10
CCC Intelligent Solutions Holdings Inc. (CCCS) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference (Transcript)
Neutral9-4
CCC Intelligent Solutions Holdings Inc. (CCCS) Q2 2025 Earnings Call Transcript
Positive7-31
The earnings call summary indicates strong financial performance with revenue and EBITDA exceeding guidance, and optimistic guidance for the future. Despite some concerns about claim volumes and EvolutionIQ's impact on margins, the company's strategic initiatives, such as the integration of EvolutionIQ and positive feedback on new products, are well-received. The Q&A section reveals a positive sentiment from analysts, with management providing reassuring insights on customer adoption and competitive positioning. These factors, combined with positive revenue growth and guidance, suggest a positive stock price movement.
CCCS Slides
CCCS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
